Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.46 |
| ▸ | LOXL2 | Q9Y4K0 | 6/20 | 0.43 |
| ▸ | ABAT | P80404 | 1/20 | 0.42 |
| ▸ | PNMT | P11086 | 1/20 | 0.41 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.41 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | LOX | P28300 | 1/20 | 0.38 |
| ▸ | LOXL3 | P58215 | 1/20 | 0.38 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29760412 | 1.00 | HRH3 (0.46) | HRH3LOXL2ABATPNMTENPP2 | |
| SCHEMBL14864128 | 0.85 | CSNK2A1 (0.47) | HRH3LOXL2ABATPNMTENPP2 | |
| SCHEMBL13443568 | 0.85 | CSNK2A1 (0.47) | HRH3LOXL2ABATPNMTENPP2 | |
| SCHEMBL23199297 | 0.82 | EGFR (0.39) | HRH3LOXL2ABATENPP2 | |
| SCHEMBL17196243 | 0.79 | LOXL2 (0.46) | HRH3LOXL2ABATPNMTENPP2 | |
| SCHEMBL24372740 | 0.79 | CNR1 (0.45) | TAAR1 | |
| SCHEMBL1696358 | 0.77 | CSNK2A1 (0.49) | HRH3LOXL2ABATPNMTENPP2 | |
| SCHEMBL22499985 | 0.77 | BACE1 (0.52) | HRH3LOXL2ABATENPP2GAA | |
| SCHEMBL21699644 | 0.77 | HRH3 (0.40) | HRH3LOXL2ABATPNMTENPP2 | |
| SCHEMBL2007285 | 0.77 | LOXL2 (0.48) | HRH3LOXL2ABATPNMTENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250092509-A1 | SELECTIVE DEPOSITION OF ORGANIC POLYMER MATERIAL AND DEPOSITION ASSEMBLIES | ASM IP HOLDING B.V. (NL) | 2025-03-20 | — | — | US | claimed |
| EP-3805197-B1 | METHOD FOR PRODUCING COMPOUND, COMPOUND, EPOXY CURING AGENT, AND METHOD FOR PRODUCING AMINE COMPOSITION | MITSUBISHI GAS CHEMICAL CO (JP) | 2023-12-06 | — | — | EP | claimed |
| EP-3638663-B1 | PRODUCTION OF TRI-METHYL BENZENE DERIVATIVES | RHODIA OPERATIONS (FR) | 2021-11-17 | — | — | EP | claimed |
| CN-112166100-A | Method for producing compound, epoxy curing agent, and method for producing amine composition | 三菱瓦斯化学株式会社 | 2021-01-01 | — | — | CN | claimed |
| US-20200216382-A1 | PRODUCTION OF TRI-METHYL BENZENE DERIVATIVES | SPECIALTY OPERATIONS FRANCE (FR) | 2020-07-09 | — | — | US | claimed |
| EP-3638663-A1 | PRODUCTION OF TRI-METHYL BENZENE DERIVATIVES | Rhodia Operations (FR) | 2020-04-22 | — | — | EP | claimed |
| WO-2018229237-A1 | PRODUCTION OF TRI-METHYL BENZENE DERIVATIVES | RHODIA OPERATIONS (FR) | 2018-12-20 | — | — | WO | claimed |
| US-20250137118-A1 | POLYMERIC INHIBITOR FOR AREA SELECTIVE DEPOSITION | ASM IP HOLDING B.V. (NL) | 2025-05-01 | — | — | US | disclosed |
| US-20250092509-A1 | SELECTIVE DEPOSITION OF ORGANIC POLYMER MATERIAL AND DEPOSITION ASSEMBLIES | ASM IP HOLDING B.V. (NL) | 2025-03-20 | — | — | US | disclosed |
| US-20240294956-A1 | ASPARTIC ACID COMPOSITION, POLYSUCCINIMIDE COMPOSITION, POLYASPARTIC ACID COMPOSITION, AND CROSS-LINKED POLYASPARTIC ACID COMPOSITION | DIC CORPORATION (JP) | 2024-09-05 | — | — | US | disclosed |
| CN-118109802-A | Method of forming organic polymer comprising polyimide | ASM IP私人控股有限公司 | 2024-05-31 | — | — | CN | disclosed |
| US-20240177992-A1 | METHOD OF FORMING AN ORGANIC POLYMER COMPRISING POLYIMIDE | ASM IP HOLDING B.V. (NL) | 2024-05-30 | — | — | US | disclosed |
| EP-4365219-A1 | ASPARTIC ACID COMPOSITION, POLYSUCCINIMIDE COMPOSITION, POLYASPARTIC ACID COMPOSITION, AND CROSS-LINKED POLYASPARTIC ACID COMPOSITION | DIC Corporation (JP) | 2024-05-08 | — | — | EP | disclosed |
| US-20110166299-A1 | ELECTRET AND ELECTROSTATIC INDUCTION CONVERSION DEVICE | ASAHI GLASS COMPANY, LIMITED | 2011-07-07 | — | — | US | disclosed |
| EP-2330159-A1 | ELECTRET AND ELECTROSTATIC INDUCTION CONVERSION DEVICE | Asahi Glass Company Limited (JP) | 2011-06-08 | — | — | EP | disclosed |
| US-20100292148-A1 | TARGETED POLYLYSINE DENDRIMER THERAPEUTIC AGENT | STARPHARMA PTY LTD. (AU) | 2010-11-18 | — | — | US | disclosed |
| US-20100278750-A1 | POLYLYSINE DENDRIMER CONTRAST AGENT | STARPHARMA PTY LTD | 2010-11-04 | — | — | US | disclosed |
| US-20090118467-A1 | Macromolecular Compounds Having Controlled Stoichiometry | STARPHARMA PTY LIMITED (AU) | 2009-05-07 | — | — | US | disclosed |
| US-7189770-B2 | Curing component and curable resin composition containing the curing component | THE YOKOHAMA RUBBER CO., LTD. (JP) | 2007-03-13 | — | — | US | disclosed |
| US-20040116644-A1 | Curing component and curable resin composition containing the curing component | YOKOHAMA RUBBER CO., LTD., THE (JP) | 2004-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100278750-A1 | POLYLYSINE DENDRIMER CONTRAST AGENT | PARG, PARN, TLR3 | HRH3 427/4885LOXL2 655/4885ABAT 3407/4885 |
| US-20090118467-A1 | Macromolecular Compounds Having Controlled Stoichiometry | MICA, PICALM, CLTB | HRH3 1105/4885LOXL2 3680/4885ABAT 2930/4885 |
| US-20200216382-A1 | PRODUCTION OF TRI-METHYL BENZENE DERIVATIVES | TET1, TERF2, TET2 | HRH3 2203/4885LOXL2 3784/4885ABAT 77/4885 |
| US-20100292148-A1 | TARGETED POLYLYSINE DENDRIMER THERAPEUTIC AGENT | CLTA, PARG, FLT3 | HRH3 961/4885LOXL2 1241/4885ABAT 2698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.